STAT+: Oral ketamine tablets effective for treating depression, new study finds
STAT
JUNE 24, 2024
In the Phase 2 trial, the results of which were detailed in Nature Medicine , patients who took extended release ketamine tablets at an 180mg dosage twice weekly showed a “statistically significant and clinically meaningful improvement in depressive symptoms” compared to a placebo. Other dosages saw less of an impact.
Let's personalize your content